Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases

被引:2
|
作者
Jankowska, Katarzyna [1 ]
Dudek, Piotr [1 ]
Stasiek, Malgorzata [2 ]
Suchta, Katarzyna [3 ]
机构
[1] Bielanski Hosp, Ctr Postgrad Med Educ, Dept Endocrinol, 80 Ceglowska St, PL-01809 Warsaw, Poland
[2] Natl Inst Geriatr Rheumatol & Rehabil, Biol Therapy Ctr, Warsaw, Poland
[3] Med Univ Warsaw, Dept Gynaecol Endocrinol, Warsaw, Poland
来源
REUMATOLOGIA | 2023年 / 61卷 / 04期
关键词
Hashimoto's disease; rheumatoid arthritis; endocrinopathies; autoimmune polyendocri-ne syndromes; autoantibodies; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; DIABETES-MELLITUS RISK; PITUITARY-ADRENAL AXIS; LOW SERUM-LEVELS; THYROID-DISEASE; CELIAC-DISEASE; PREMENOPAUSAL WOMEN; ADDISONS-DISEASE; NECROSIS-FACTOR;
D O I
10.5114/reum/170266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoimmune polyendocrine syndromes (APSs), also called autoimmune polyglandular syndromes, are a group of autoimmune diseases characterized by the co-occurrence of dysfunctions of several (at least two) endocrine glands. They develop under the influence of environmental factors in genetically predisposed people. Autoimmune polyendocrine syndromes may accompany autoimmune rheumatic diseases and worsen their course - APS-2 and APS-3 are the most common. The APS-2 includes the coexistence of, e.g. Hashimoto's disease, celiac disease and rheumatoid arthritis (RA). In APS-3, rheumatic diseases such as RA, systemic lupus erythematosus, and Sjogren's syndrome may coexist with Hashimoto's disease, type 1 diabetes and hypogonadism or other endocrinopathies. Undiagnosed endocrine diseases may be the reason for the intensification of metabolic disorders observed in the course of rheumatic diseases, cause the ineffectiveness of rheumatological treatment and also increase the frequency of bone fractures due to osteoporosis, cardiovascular complications and even miscarriages when coexistent, e.g. Hashimoto's disease with hypothyroiditis, which increases the risk of pregnancy loss. It is important to be able to conduct an extensive interview, paying attention to the symptoms of possible endocrinopathy as well as the features of other autoimmune disorders in the physical examination (e.g. vitiligo or darkening of the skin in Addison's disease). Depending on the history and physical examination, screening for various APSs is advised.
引用
收藏
页码:225 / 238
页数:14
相关论文
共 50 条
  • [31] Atherosclerosis in autoimmune rheumatic diseases
    Szekanecz, Zoltan
    Kerekes, Gyorgy
    Shoenfeld, Yehuda
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 115 : 46 - 47
  • [32] Autoimmune rheumatic diseases and the heart
    Hussain, S
    Isenberg, DA
    HOSPITAL MEDICINE, 1999, 60 (02): : 95 - 99
  • [33] Geoepidemiology of autoimmune rheumatic diseases
    Shapira, Yinon
    Agmon-Levin, Nancy
    Shoenfeld, Yehuda
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (08) : 468 - 476
  • [34] Malignancies and autoimmune rheumatic diseases
    Ehrenfeld, M
    Shoenfeld, Y
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (01) : 47 - 50
  • [35] Geoepidemiology of autoimmune rheumatic diseases
    Yinon Shapira
    Nancy Agmon-Levin
    Yehuda Shoenfeld
    Nature Reviews Rheumatology, 2010, 6 : 468 - 476
  • [36] Vaccination and autoimmune rheumatic diseases
    Conti, Fabrizio
    Rezai, Soheila
    Valesini, Guido
    AUTOIMMUNITY REVIEWS, 2008, 8 (02) : 124 - 128
  • [37] MicroRNAs in autoimmune rheumatic diseases
    Galeazzi, M.
    Balistreri, E.
    Giannitti, C.
    Sebastiani, G. D.
    REUMATISMO, 2012, 64 (01) : 7 - 17
  • [38] Curcumin in Autoimmune and Rheumatic Diseases
    Yang, Melissa
    Akbar, Umair
    Mohan, Chandra
    NUTRIENTS, 2019, 11 (05)
  • [39] Advances in autoimmune rheumatic diseases
    不详
    LANCET, 2013, 382 (9894): : 744 - 744
  • [40] Bromocriptine in rheumatic and autoimmune diseases
    McMurray, RW
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2001, 31 (01) : 21 - 32